Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Pediatr Res ; 85(3): 361-368, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30631136

RESUMEN

BACKGROUND: Premature infants often develop enteric dysbiosis with a preponderance of Gammaproteobacteria, which has been related to adverse clinical outcomes. We investigated the relationship between increasing fecal Gammaproteobacteria and mucosal inflammation, measured by fecal calprotectin (FC). METHODS: Stool samples were collected from very-low-birth weight (VLBW) infants at ≤2, 3, and 4 weeks' postnatal age. Fecal microbiome was surveyed using polymerase chain reaction amplification of the V4 region of 16S ribosomal RNA, and FC was measured by enzyme immunoassay. RESULTS: We enrolled 45 VLBW infants (gestation 27.9 ± 2.2 weeks, birth weight 1126 ± 208 g) and obtained stool samples at 9.9 ± 3, 20.7 ± 4.1, and 29.4 ± 4.9 days. FC was positively correlated with the genus Klebsiella (r = 0.207, p = 0.034) and its dominant amplicon sequence variant (r = 0.290, p = 0.003), but not with the relative abundance of total Gammaproteobacteria. Klebsiella colonized the gut in two distinct patterns: some infants started with low Klebsiella abundance and gained these bacteria over time, whereas others began with very high Klebsiella abundance. CONCLUSION: In premature infants, FC correlated with relative abundance of a specific pathobiont, Klebsiella, and not with that of the class Gammaproteobacteria. These findings indicate a need to define dysbiosis at genera or higher levels of resolution.


Asunto(s)
Disbiosis/diagnóstico , Complejo de Antígeno L1 de Leucocito/análisis , Peso al Nacer , Disbiosis/microbiología , Enterocolitis Necrotizante/microbiología , Heces/química , Femenino , Gammaproteobacteria/aislamiento & purificación , Microbioma Gastrointestinal , Edad Gestacional , Humanos , Lactante , Recien Nacido Extremadamente Prematuro , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro , Recién Nacido de muy Bajo Peso , Inflamación , Unidades de Cuidado Intensivo Neonatal , Infecciones por Klebsiella/diagnóstico , Masculino , Estudios Prospectivos , ARN Ribosómico 16S , Curva ROC , Sensibilidad y Especificidad
2.
Pediatr Res ; 81(5): 817-824, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28085792

RESUMEN

BACKGROUND: Thrombocytopenia is frequently encountered in infants with necrotizing enterocolitis (NEC). To develop a preclinical model of NEC-related thrombocytopenia, we measured serial platelet counts in 10-d-old (P10) mouse pups with trinitrobenzene sulfonic acid (TNBS)-induced NEC-like injury. We also measured platelet volume indices, immature platelet fraction (IPF), and megakaryocyte number/ploidy in these animals. METHODS: Platelet counts, platelet volume indices, and IPF were measured in control (N = 65) and TNBS-treated pups (N = 104) using an automated hematology analyzer. Bone marrow megakaryocyte number, ploidy and CD41 expression were measured by flow cytometry. These findings were confirmed in a small cohort of P3 mice with NEC-like injury. RESULTS: Murine pups with TNBS-mediated NEC-like injury developed thrombocytopenia at 15-24 h after exposure to TNBS. Intestinal injury was associated with increased platelet volume indices (mean platelet volume, platelet-to-large cell ratio, and platelet distribution width), and IPF, indicating increased thrombopoiesis. These mice also showed increased megakaryocyte number, ploidy, and CD41 expression, indicating increased megakaryocyte differentiation. CONCLUSION: Similar to human NEC, murine NEC-like injury was also associated with decreased platelet counts. There was evidence of increased megakaryocyte differentiation and thrombopoiesis, which favors peripheral consumption of platelets as the likely mechanism of thrombocytopenia in these animals, over decreased platelet production.


Asunto(s)
Plaquetas , Enterocolitis Necrotizante/sangre , Megacariocitos , Trombocitopenia/sangre , Trombopoyesis , Animales , Animales Recién Nacidos , Biomarcadores/sangre , Plaquetas/metabolismo , Plaquetas/patología , Modelos Animales de Enfermedad , Enterocolitis Necrotizante/inducido químicamente , Enterocolitis Necrotizante/patología , Intestinos/patología , Volúmen Plaquetario Medio , Megacariocitos/metabolismo , Megacariocitos/patología , Ratones Endogámicos C57BL , Recuento de Plaquetas , Glicoproteína IIb de Membrana Plaquetaria/sangre , Ploidias , Trombocitopenia/etiología , Trombocitopenia/patología , Factores de Tiempo , Ácido Trinitrobencenosulfónico
3.
Pediatr Res ; 81(1-1): 99-112, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27656771

RESUMEN

BACKGROUND: We have shown previously that enteral administration of 2, 4, 6-trinitrobenzene sulfonic acid in 10-d-old C57BL/6 pups produces an acute necrotizing enterocolitis with histopathological and inflammatory changes similar to human necrotizing enterocolitis (NEC). To determine whether murine neonatal 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-mediated intestinal injury could be used as a NEC model, we compared gene expression profiles of TNBS-mediated intestinal injury and NEC. METHODS: Whole-genome microarray analysis was performed on proximal colon from control and TNBS-treated pups (n = 8/group). For comparison, we downloaded human microarray data of NEC (n = 5) and surgical control (n = 4) from a public database. Data were analyzed using the software programs Partek Genomics Suite and Ingenuity Pathway Analysis. RESULTS: We detected extensive changes in gene expression in murine TNBS-mediated intestinal injury and human NEC. Using fold-change cut-offs of ±1.5, we identified 4,440 differentially-expressed genes (DEGs) in murine TNBS-mediated injury and 1,377 in NEC. Murine TNBS-mediated injury and NEC produced similar changes in expression of orthologous genes (r = 0.611, P < 0.001), and also activated nearly-identical biological processes and pathways. Lipopolysaccharide was top predicted upstream regulator in both the murine and human datasets. CONCLUSION: Murine neonatal TNBS-mediated enterocolitis and human NEC activate nearly-identical biological processes, signaling pathways, and transcriptional networks.


Asunto(s)
Enterocolitis Necrotizante/genética , Redes Reguladoras de Genes/efectos de los fármacos , Mucosa Intestinal/metabolismo , Intestinos/lesiones , Ácido Trinitrobencenosulfónico/toxicidad , Animales , Animales Recién Nacidos , Modelos Animales de Enfermedad , Enterocolitis Necrotizante/etiología , Perfilación de la Expresión Génica , Humanos , Intestinos/efectos de los fármacos , Lipopolisacáridos/toxicidad , Ratones , Ratones Endogámicos C57BL , Especificidad de la Especie
4.
Newborn (Clarksville) ; 1(1): 120-130, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35754997

RESUMEN

The incomplete understanding of the etiopathogenesis of necrotizing enterocolitis (NEC) contributes to the lack of timely diagnosis and limited therapeutic options. Non-coding RNAs (ncRNAs) have emerged as key regulators of gene expression in various pathways that can modulate various physiological and pathological processes. Despite several studies revealing the role of ncRNAs in intestinal inflammatory diseases in adults, these remain largely unexplored in NEC. In this article, we review the information on ncRNAs that have been specifically identified in NEC or have been noted in other inflammatory bowel disorders that share some of the histopathological abnormalities seen frequently in NEC. We have assimilated the most current research findings on ncRNAs in intestinal diseases. This is an attempt to explore a novel field that has immense potential for future translational and clinical research in preventing, detecting, and treating NEC.

5.
Curr Pediatr Rev ; 18(3): 197-209, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35040407

RESUMEN

The etiopathogenesis of necrotizing enterocolitis (NEC) remains unclear, but increasing information suggests that the risk and severity of NEC may be influenced by single nucleotide polymorphisms in many genes. In this article, we have reviewed gene variations that have either been specifically identified in NEC or have been noted in other inflammatory bowel disorders with similar histopathological abnormalities. We present evidence from our own peer-reviewed laboratory studies and data from an extensive literature search in the databases PubMed, EMBASE, and Scopus. To avoid bias in the identification of existing studies, search keywords were short-listed both from our own studies and from PubMed's Medical Subject Heading (MeSH) thesaurus.


Asunto(s)
Enterocolitis Necrotizante , Enfermedades del Recién Nacido , Enterocolitis Necrotizante/diagnóstico , Enterocolitis Necrotizante/genética , Humanos , Recién Nacido , Polimorfismo de Nucleótido Simple
6.
Nat Commun ; 10(1): 3494, 2019 08 02.
Artículo en Inglés | MEDLINE | ID: mdl-31375667

RESUMEN

Necrotizing enterocolitis (NEC) is an idiopathic, inflammatory bowel necrosis of premature infants. Clinical studies have linked NEC with antecedent red blood cell (RBC) transfusions, but the underlying mechanisms are unclear. Here we report a neonatal murine model to investigate this association. C57BL/6 mouse pups rendered anemic by timed phlebotomy and then given RBC transfusions develop NEC-like intestinal injury with prominent necrosis, inflammation, and submucosal edema/separation of the lamina propria in the ileocecal region and colon within 12-24 h. The anemic intestine is infiltrated by inflammatory macrophages, which are activated in situ by RBC transfusions via a Toll-like receptor (TLR)-4-mediated mechanism and cause bowel injury. Chelation of RBC degradation products with haptoglobin, absence of TLR4, macrophage depletion, and inhibition of macrophage activation is protective. Intestinal injury worsens with increasing severity and the duration of anemia prior to transfusion, indicating a need for the re-evaluation of current transfusion guidelines for premature infants.


Asunto(s)
Anemia/complicaciones , Enterocolitis Necrotizante/etiología , Transfusión de Eritrocitos/efectos adversos , Enfermedades del Recién Nacido/etiología , Anemia/terapia , Animales , Animales Recién Nacidos , Ciego/patología , Colon/patología , Modelos Animales de Enfermedad , Enterocolitis Necrotizante/patología , Humanos , Íleon/patología , Recién Nacido , Enfermedades del Recién Nacido/patología , Recien Nacido Prematuro , Mucosa Intestinal/patología , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Receptor Toll-Like 4/inmunología , Receptor Toll-Like 4/metabolismo
7.
Microbiome ; 6(1): 157, 2018 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-30208950

RESUMEN

BACKGROUND: Preterm infants are at risk of developing intestinal dysbiosis with an increased proportion of Gammaproteobacteria. In this study, we sought the clinical determinants of the relative abundance of feces-associated Gammaproteobacteria in very low birth weight (VLBW) infants. Fecal microbiome was characterized at ≤ 2 weeks and during the 3rd and 4th weeks after birth, by 16S rRNA amplicon sequencing. Maternal and infant clinical characteristics were extracted from electronic medical records. Data were analyzed by linear mixed modeling and linear regression. RESULTS: Clinical data and fecal microbiome profiles of 45 VLBW infants (gestational age 27.9 ± 2.2 weeks; birth weight 1126 ± 208 g) were studied. Three stool samples were analyzed for each infant at mean postnatal ages of 9.9 ± 3, 20.7 ± 4.1, and 29.4 ± 4.9 days. The average relative abundance of Gammaproteobacteria was 42.5% (0-90%) at ≤ 2 weeks, 69.7% (29.9-86.9%) in the 3rd, and 75.5% (54.5-86%) in the 4th week (p < 0.001). Hierarchical and K-means clustering identified two distinct subgroups: cluster 1 started with comparatively low abundance that increased with time, whereas cluster 2 began with a greater abundance at ≤ 2 weeks (p < 0.001) that decreased over time. Both groups resembled each other by the 3rd week. Single variants of Klebsiella and Staphylococcus described variance in community structure between clusters and were shared between all infants, suggesting a common, hospital-derived source. Fecal Gammaproteobacteria was positively associated with vaginal delivery and antenatal steroids. CONCLUSIONS: We detected a dichotomy in gut microbiome assembly in preterm infants: some preterm infants started with low relative gammaproteobacterial abundance in stool that increased as a function of postnatal age, whereas others began with and maintained high abundance. Vaginal birth and antenatal steroids were identified as predictors of Gammaproteobacteria abundance in the early (≤ 2 weeks) and later (3rd and 4th weeks) stool samples, respectively. These findings are important in understanding the development of the gut microbiome in premature infants.


Asunto(s)
Gammaproteobacteria/aislamiento & purificación , Microbioma Gastrointestinal , Recien Nacido Prematuro , Recién Nacido de muy Bajo Peso , Heces/microbiología , Femenino , Gammaproteobacteria/clasificación , Gammaproteobacteria/genética , Gammaproteobacteria/crecimiento & desarrollo , Tracto Gastrointestinal/microbiología , Edad Gestacional , Humanos , Recién Nacido , Recien Nacido Prematuro/crecimiento & desarrollo , Recién Nacido de muy Bajo Peso/crecimiento & desarrollo , Masculino
8.
Semin Perinatol ; 41(1): 52-60, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27832931

RESUMEN

Cytokines and growth factors play diverse roles in the uninflamed fetal/neonatal intestinal mucosa and in the development of inflammatory bowel injury during necrotizing enterocolitis (NEC). During gestational development and the early neonatal period, the fetal/premature intestine is exposed to high levels of many "inflammatory" cytokines and growth factors, first via swallowed amniotic fluid in utero and then, after birth, in colostrum and mother's milk. This article reviews the dual, seemingly counter-intuitive roles of cytokines, where these agents play a "trophic" role and promote maturation of the uninflamed mucosa, but can also cause inflammation and promote intestinal injury during NEC.


Asunto(s)
Citocinas/metabolismo , Enterocolitis Necrotizante/fisiopatología , Factor de Crecimiento Similar a EGF de Unión a Heparina/metabolismo , Enfermedades del Prematuro/fisiopatología , Inflamación/fisiopatología , Mucosa Intestinal/fisiopatología , Susceptibilidad a Enfermedades/inmunología , Enterocolitis Necrotizante/inmunología , Enterocolitis Necrotizante/metabolismo , Regulación del Desarrollo de la Expresión Génica/inmunología , Humanos , Inmunidad Innata , Fenómenos Fisiológicos Nutricionales del Lactante , Recien Nacido con Peso al Nacer Extremadamente Bajo , Recien Nacido Extremadamente Prematuro , Recién Nacido , Enfermedades del Prematuro/inmunología , Enfermedades del Prematuro/metabolismo , Inflamación/inmunología , Mucosa Intestinal/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA